The Bioservices team at Emergent takes on challenging science for a challenged world. That leads naturally to our singular focus: putting life-saving, life-extending therapies in the hands of patients who need them. We do that by collaborating with like-minded science leaders to research, develop, and manufacture therapeutics and vaccines.
We are the Bioservices (CDMO) division of Emergent BioSolutions (NYSE: EBS), a biopharmaceutical company dedicated to protecting and enhancing lives.
Emergent BioSolutions specializes in confronting — and combating — the most serious intentional and natural threats to public health, including anthrax, Ebola, smallpox, botulism, and opioid addiction. The company has been proud to serve as a leading provider of antiviral, antimicrobial, and hyperimmune products for the United States and a host of other nations for over two decades.
So while the Emergent brand may be best-known as the maker of products like BioThrax® vaccine and NARCAN® nasal spray, our Bioservices clients have come to rely on our capabilities, resources, and unique experience to manufacture their live-saving, life-enhancing products.
For additional information about our specialized service offerings, please contact us directly.
If you are interested in working with Emergent, want to find out more information about our CDMO services, or would like to have us contact you for any reason, please use this web form to send us your information or questions.
.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}